Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6.
Agrawal R MD, FCRS, Gunasekeran DV MBBS, Agarwal A MS, Testi I MD, Carreño E MD, Westcott M FRCOphth, Mahajan S MBBS, Raje D PhD, Aggarwal K MS, Murthy SI DNB, Chee SP FRCSEd, Mccluskey P MD, Ho SL FRCSGlasg, Teoh S FRCSEd, Cimino L MD, Biswas J MS, Narain S MD, Agarwal M MS, Mahendradas P DNB, Khairallah M MD, Jones N FRCSOphth, Tugal-Tutkun I MD, Babu K DNB, Basu S MS, Lee R PhD, Al-Dhibi H MD, Bodaghi B MD, Invernizzi A MD, Goldstein DA MD, Herbort CP MD, Barisani-Asenbauer T PhD, González-López JJ PhD, Androudi S MD, Bansal R MS, Moharana B MS, Esposti SD MD, Tasiopoulou A MD, Nadarajah S MD, Agarwal M DNB, Abraham S MD, Vala R MD, Singh R MS, Sharma A MD, Sharma K PhD, Zierhut M PhD, Kon OM MRCP, Cunningham ET PhD, Kempen JH PhD, Nguyen QD PhD, Pavesio C FRCSOphth, Gupta V MS.
Agrawal R MD, FCRS, et al.
Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):49-57. doi: 10.1080/09273948.2020.1774905. Epub 2020 Jun 30.
Ocul Immunol Inflamm. 2020.
PMID: 32600169
Objective: Aim of the study was to examine extent, natural history, and clinical features associated with visual impairment (VI) in patients diagnosed with ocular tuberculosis (OTB) by the Collaborative Ocular Tuberculosis Study (COTS)-1.Methods: Multi-center retrospective …
Objective: Aim of the study was to examine extent, natural history, and clinical features associated with visual impairment (VI) in p …